The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma
Open accessAbstract
BACKGROUND: The overexpression of glucose transporters, especially of Glut‐1, is a common characteristic of human malignancies, including head and neck carcinoma. Recently, the assessment of glucose metabolism in the tumor with [18 F]‐2‐fluoro‐2 deoxy‐D‐glucose (FDG) and positron emission tomography (FDG‐PET) has been used to identify particularly aggressive tumors. The authors tested the hypothesis that both glucose transport and its metabolism play a key role in the progression of oral squamous cell carcinoma (OSCC). METHODS: Retrospective analysis of Glut‐1 expression was performed by immunohistology in 118 patients with OSCC, and a Glut‐1 labeling index (LI) was established for each. A separate group of 44 patients with primary OSCC was evaluated prospectively by FDG‐PET prior to surgery. To link the expression of Glut‐1 with glucose metabolism, both FDG‐PET and immunohistology were determined in a subgroup of 31 patients, and the results were correlated with overall survival. RESULTS: The patients who had OSCC with a low LI for Glut‐1 survived significantly longer compared with patients who had OSCC with a high LI (138 months vs. 60 months; P = 0.0034). It was found that Glut‐1 expression was an independent marker of prognosis in patients with OSCC. In patients who were evaluated by FDG‐PET, the standardized uptake value (SUV) below the median split value of 5.6 was predictive of a longer survival (P < 0.027), whereas an SUV > 5.6 was associated with an increased hazard of death. In combination, a high Glut‐1 level and a high SUV predicted shorter survival (P < 0.005) for patients with OSCC. Patients who achieved a complete response to preoperative radiation tended to have tumors with low glucose metabolism, as defined by both the Glut‐1 LI and the SUV. CONCLUSIONS: Both glucose transport and glucose metabolism determine the glycolytic tumor phenotype, which is a significant negative biomarker of prognosis and overall survival in patients with OSCC. Cancer 2003;97:1015–24. © 2003 American Cancer Society. DOI 10.1002/cncr.11159
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297 · cited 1×
“All of these proteins share a 12-transmembrane-spanner (TMS) protein topology, which is believed to be a result of intragenic duplication of a primordial 6-TMS unit.(6) In vitro, Glut-1 overexpression is an early event after ras and src transformation,(7) and a promotive effect of ras through the HIF-1 -binding site o…”
BackgroundThe applications of PET in clinical oncology.
Strauss, L. G., & Conti, P. S. (1991) · PubMed · Cited by 844
Flier, J. S., Mueckler, M. M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 786
TNM Klassifikation maligner Tumoren
Cancer, U. I. U. A. (1987) · Springer eBooks · doi:10.1007/978-3-662-10565-8 · Cited by 775
Regulation of glut1 mRNA by Hypoxia-inducible Factor-1
Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F., & Maity, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010144200 · Cited by 771
Zasadny, K. R., & Wahl, R. L. (1993) · Radiology · doi:10.1148/radiology.189.3.8234714 · Cited by 635
Over-expression of facilitative glucose transporter genes in human cancer
Yamamoto, T., Seino, Y., Fukumoto, H., Koh, G., Yano, H., Inagaki, N., Yamada, Y., Inoue, K., Manabe, T., & Imura, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91263-r · Cited by 465
Vansteenkiste, J. F., Stroobants, S. G., Dupont, P. J., De Leyn, P. R., Verbeken, E. K., Deneffe, G. J., Mortelmans, L. A., & Demedts, M. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3201 · Cited by 439
Younes, M., Brown, R. W., Stephenson, M., Gondo, M., & Cagle, P. T. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970915)80:6<1046::aid-cncr6>3.0.co;2-7 · Cited by 381
Airley, R. E., Loncaster, J. A., Davidson, S. E., Bromley, M., Roberts, S. K., Patterson, A. V., Hunter, R. D., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 363
Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Younes, M., Lechago, L. V., Somoano, J. R., Mosharaf, M., & Lechago, J. (1996) · PubMed · Cited by 338
Ahuja, V., Coleman, R. E., Herndon, J., & Patz, E. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980901)83:5<918::aid-cncr17>3.0.co;2-y · Cited by 331
A unique glucose-dependent apoptotic pathway induced by c-Myc
Shim, H., Chun, Y. S., Lewis, B. C., & Dang, C. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1511 · Cited by 286
Kawamura, T., Kusakabe, T., Sugino, T., Watanabe, K., Fukuda, T., Nashimoto, A., Honma, K., & Suzuki, T. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<634::aid-cncr1364>3.0.co;2-x · Cited by 276
über den Stoffwechsel der Carcinomzelle
Warburg, O. (1925) · Klinische Wochenschrift · doi:10.1007/bf01726151 · Cited by 253
Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Minn, H. R. I., Lapela, M., Klemi, P. J., Grenman, R. A., Leskinen, S., Lindholm, P., Bergman, J., Eronen, E., Haaparanta, M., & Joensuu, H. (1997) · PubMed · Cited by 232
Oshida, M., Uno, K., Suzuki, M., Nagashima, T., Hashimoto, H., Yagata, H., Shishikura, T., Imazeki, K., & Nakajima, N. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w · Cited by 230
Allal, A. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1398 · Cited by 219
FDG–PET. A possible prognostic factor in head and neck cancer
Halfpenny, W., Hain, S. F., Biassoni, L., Maisey, M. N., Sherman, J. A., & McGurk, M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600114 · Cited by 205
Reichert, T. E., Scheuer, C., Day, R., Wagner, W., & Whiteside, T. L. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2136::aid-cncr1242>3.0.co;2-q · Cited by 162
Self-citationExpression of glucose transporters in head‐and‐neck tumors
Mellanen, P., Minn, H. R. I., Grenman, R. A., & Härkönen, P. L. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560503 · Cited by 159
[18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer✩
Dhital, K. K., Saunders, C. A. B., Seed, P. T., O'Doherty, M. J., & Dussek, J. E. (2000) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(00)00535-2 · Cited by 151
Reichert, T. E., Day, R., Wagner, E. M., & Whiteside, T. L. (1998) · PubMed · Cited by 147
Self-citationAssessment of Antigen Damage in Immunohistochemistry: The Vimentin Internal Control
Battifora, H. A. (1991) · American Journal of Clinical Pathology · doi:10.1093/ajcp/96.5.669 · Cited by 129
Reisser, C., Eichhorn, K., Herold‐Mende, C. C., Born, A. I., & Bannasch, P. (1999) · International Journal of Cancer · Cited by 87
Glut3 Expression in Biopsy Specimens of Laryngeal Carcinoma Is Associated With Poor Survival
Baer, S., Casaubon, L., Schwartz, M. R., Marcogliese, A. N., & Younes, M. (2002) · The Laryngoscope · doi:10.1097/00005537-200202000-00034 · Cited by 55
Chang, S., Lee, S., Lee, C., Kim, J. I., & Kim, Y.-W. (2000) · Urology · doi:10.1016/s0090-4295(99)00474-4 · Cited by 50
Mohr, C., Bohndorf, W., Gremmel, H., Härle, F., Hausamen, J.-E., Hirche, H., Molls, M., Renner, K., Reuther, J. F., Sack, H., et al. (1994) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-84971-8_17 · Cited by 13
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3
Cited by
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Tixier, F., Le Rest, C. C., Hatt, M., Albarghach, N., Pradier, O., Metges, J.-P., Corcos, L., & Visvikis, D. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082404 · Cited by 696
Oral squamous cell carcinoma: Review of prognostic and predictive factors
Massano, J., Regateiro, F. S., Januário, G., & Ferreira, A. (2006) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2005.07.038 · Cited by 638
San-Millán, I., & Brooks, G. A. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw127 · Cited by 610
Metadata
- Authors
- Kunkel, M., Reichert, T. E., Benz, P., Lehr, H., Jeong, J., Wieand, S., Bartenstein, P., Wagner, W., & Whiteside, T. L.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-02-03
- Volume
- 97
- Issue
- 4
- Pages
- 1015-1024
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1963901057
- Cited by
- 390
- References
- 30
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.